 | • レポートコード：MRC2102QY6746 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、149ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のヒトB型肝炎免疫グロブリン（HBIG）市場について種類別（100IU/ボトルヒトB型肝炎免疫グロブリン、200IU/ボトルヒトB型肝炎免疫グロブリン、400IU/ボトルヒトB型肝炎免疫グロブリン）、用途別（B型肝炎表面抗原（HBsAg）母親陽性乳児、予測不可B型肝炎感染群集、B型肝炎・B型肝炎ウイルスキャリア患者密接接触）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・ヒトB型肝炎免疫グロブリン（HBIG）市場の概要 ・世界の主要地域別ヒトB型肝炎免疫グロブリン（HBIG）市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のヒトB型肝炎免疫グロブリン（HBIG）市場規模2015-2026：種類別（100IU/ボトルヒトB型肝炎免疫グロブリン、200IU/ボトルヒトB型肝炎免疫グロブリン、400IU/ボトルヒトB型肝炎免疫グロブリン） ・世界のヒトB型肝炎免疫グロブリン（HBIG）市場規模2015-2026：用途別（B型肝炎表面抗原（HBsAg）母親陽性乳児、予測不可B型肝炎感染群集、B型肝炎・B型肝炎ウイルスキャリア患者密接接触） ・ヒトB型肝炎免疫グロブリン（HBIG）の米国市場規模2015-2020 ・ヒトB型肝炎免疫グロブリン（HBIG）のヨーロッパ市場規模2015-2020 ・ヒトB型肝炎免疫グロブリン（HBIG）の中国市場規模2015-2020 ・ヒトB型肝炎免疫グロブリン（HBIG）の日本市場規模2015-2020 ・ヒトB型肝炎免疫グロブリン（HBIG）の東南アジア市場規模2015-2020 ・ヒトB型肝炎免疫グロブリン（HBIG）のインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・ヒトB型肝炎免疫グロブリン（HBIG）の製造コスト分析 ・販売チャネル、流通業者、顧客 ・ヒトB型肝炎免疫グロブリン（HBIG）の市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin (HBIG) Market
The global Human Hepatitis B Immunoglobulin (HBIG) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026.
Global Human Hepatitis B Immunoglobulin (HBIG) Scope and Market Size
The global Human Hepatitis B Immunoglobulin (HBIG) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Human Hepatitis B Immunoglobulin (HBIG) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Human Hepatitis B Immunoglobulin (HBIG) market is segmented into
100IU/Bottle Human Hepatitis B Immunoglobulin
200IU/Bottle Human Hepatitis B Immunoglobulin
400IU/Bottle Human Hepatitis B Immunoglobulin
Segment by Application, the Human Hepatitis B Immunoglobulin (HBIG) market is segmented into
Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
Unexpected Crowd of Hepatitis B Infection
Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
The Human Hepatitis B Immunoglobulin (HBIG) market is analysed and market size information is provided by regions (countries). Segment by Application, the Human Hepatitis B Immunoglobulin (HBIG) market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Human Hepatitis B Immunoglobulin (HBIG) Market Share Analysis
Human Hepatitis B Immunoglobulin (HBIG) market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Human Hepatitis B Immunoglobulin (HBIG) business, the date to enter into the Human Hepatitis B Immunoglobulin (HBIG) market, Human Hepatitis B Immunoglobulin (HBIG) product introduction, recent developments, etc.
The major vendors covered:
Baxter
CSL
Bayer
Grifols
Octapharma
Shanghai RAAS
Hualan Biological
China Biologic
Tiantan Biologic
Shuanglin Bio-pharmacy
Sichuan Yuanda Shuyang
Boya Bio-pharmaceutical
Shanghai Institute of Biological
1 Human Hepatitis B Immunoglobulin (HBIG) Market Overview
1.1 Human Hepatitis B Immunoglobulin (HBIG) Product Scope
1.2 Human Hepatitis B Immunoglobulin (HBIG) Segment by Type
1.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales by Type (2020-2026)
1.2.2 100IU/Bottle Human Hepatitis B Immunoglobulin
1.2.3 200IU/Bottle Human Hepatitis B Immunoglobulin
1.2.4 400IU/Bottle Human Hepatitis B Immunoglobulin
1.3 Human Hepatitis B Immunoglobulin (HBIG) Segment by Application
1.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Comparison by Application (2020-2026)
1.3.2 Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg)
1.3.3 Unexpected Crowd of Hepatitis B Infection
1.3.4 Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers
1.4 Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Forecasts (2015-2026)
1.4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Growth Rate (2015-2026)
1.4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue and Growth Rate (2015-2026)
1.4.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price Trends (2015-2026)
2 Human Hepatitis B Immunoglobulin (HBIG) Estimate and Forecast by Region
2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2015-2020)
2.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region (2015-2020)
2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2015-2026)
2.4.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2015-2026)
2.4.3 China Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2015-2026)
2.4.4 Japan Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2015-2026)
2.4.6 India Human Hepatitis B Immunoglobulin (HBIG) Estimates and Projections (2015-2026)
3 Global Human Hepatitis B Immunoglobulin (HBIG) Competition Landscape by Players
3.1 Global Top Human Hepatitis B Immunoglobulin (HBIG) Players by Sales (2015-2020)
3.2 Global Top Human Hepatitis B Immunoglobulin (HBIG) Players by Revenue (2015-2020)
3.3 Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin (HBIG) as of 2019)
3.4 Global Human Hepatitis B Immunoglobulin (HBIG) Average Price by Company (2015-2020)
3.5 Manufacturers Human Hepatitis B Immunoglobulin (HBIG) Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Human Hepatitis B Immunoglobulin (HBIG) Players (Opinion Leaders)
4 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Type
4.1 Global Human Hepatitis B Immunoglobulin (HBIG) Historic Market Review by Type (2015-2020)
4.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
4.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Type (2015-2020)
4.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Type (2015-2020)
4.2 Global Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Forecast by Type (2021-2026)
4.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Forecast by Type (2021-2026)
4.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price Forecast by Type (2021-2026)
5 Global Human Hepatitis B Immunoglobulin (HBIG) Market Size by Application
5.1 Global Human Hepatitis B Immunoglobulin (HBIG) Historic Market Review by Application (2015-2020)
5.1.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
5.1.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Application (2015-2020)
5.1.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price by Application (2015-2020)
5.2 Global Human Hepatitis B Immunoglobulin (HBIG) Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Human Hepatitis B Immunoglobulin (HBIG) Sales Forecast by Application (2021-2026)
5.2.2 Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Forecast by Application (2021-2026)
5.2.3 Global Human Hepatitis B Immunoglobulin (HBIG) Price Forecast by Application (2021-2026)
6 United States Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures
6.1 United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
6.2 United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
6.3 United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
7 Europe Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures
7.1 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
7.2 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
7.3 Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
8 China Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures
8.1 China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
8.2 China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
8.3 China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
9 Japan Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures
9.1 Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (3015-3030)
9.2 Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
9.3 Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
10 Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures
10.1 Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
11 India Human Hepatitis B Immunoglobulin (HBIG) Market Facts & Figures
11.1 India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
11.2 India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
11.3 India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Human Hepatitis B Immunoglobulin (HBIG) Business
12.1 Baxter
12.1.1 Baxter Corporation Information
12.1.2 Baxter Business Overview
12.1.3 Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Baxter Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.1.5 Baxter Recent Development
12.2 CSL
12.2.1 CSL Corporation Information
12.2.2 CSL Business Overview
12.2.3 CSL Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.2.5 CSL Recent Development
12.3 Bayer
12.3.1 Bayer Corporation Information
12.3.2 Bayer Business Overview
12.3.3 Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Bayer Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.3.5 Bayer Recent Development
12.4 Grifols
12.4.1 Grifols Corporation Information
12.4.2 Grifols Business Overview
12.4.3 Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Grifols Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.4.5 Grifols Recent Development
12.5 Octapharma
12.5.1 Octapharma Corporation Information
12.5.2 Octapharma Business Overview
12.5.3 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Octapharma Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.5.5 Octapharma Recent Development
12.6 Shanghai RAAS
12.6.1 Shanghai RAAS Corporation Information
12.6.2 Shanghai RAAS Business Overview
12.6.3 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.6.5 Shanghai RAAS Recent Development
12.7 Hualan Biological
12.7.1 Hualan Biological Corporation Information
12.7.2 Hualan Biological Business Overview
12.7.3 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.7.5 Hualan Biological Recent Development
12.8 China Biologic
12.8.1 China Biologic Corporation Information
12.8.2 China Biologic Business Overview
12.8.3 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.8.4 China Biologic Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.8.5 China Biologic Recent Development
12.9 Tiantan Biologic
12.9.1 Tiantan Biologic Corporation Information
12.9.2 Tiantan Biologic Business Overview
12.9.3 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.9.5 Tiantan Biologic Recent Development
12.10 Shuanglin Bio-pharmacy
12.10.1 Shuanglin Bio-pharmacy Corporation Information
12.10.2 Shuanglin Bio-pharmacy Business Overview
12.10.3 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.10.5 Shuanglin Bio-pharmacy Recent Development
12.11 Sichuan Yuanda Shuyang
12.11.1 Sichuan Yuanda Shuyang Corporation Information
12.11.2 Sichuan Yuanda Shuyang Business Overview
12.11.3 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.11.5 Sichuan Yuanda Shuyang Recent Development
12.12 Boya Bio-pharmaceutical
12.12.1 Boya Bio-pharmaceutical Corporation Information
12.12.2 Boya Bio-pharmaceutical Business Overview
12.12.3 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.12.5 Boya Bio-pharmaceutical Recent Development
12.13 Shanghai Institute of Biological
12.13.1 Shanghai Institute of Biological Corporation Information
12.13.2 Shanghai Institute of Biological Business Overview
12.13.3 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Products Offered
12.13.5 Shanghai Institute of Biological Recent Development
13 Human Hepatitis B Immunoglobulin (HBIG) Manufacturing Cost Analysis
13.1 Human Hepatitis B Immunoglobulin (HBIG) Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (HBIG)
13.4 Human Hepatitis B Immunoglobulin (HBIG) Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Human Hepatitis B Immunoglobulin (HBIG) Distributors List
14.3 Human Hepatitis B Immunoglobulin (HBIG) Customers
15 Market Dynamics
15.1 Human Hepatitis B Immunoglobulin (HBIG) Market Trends
15.2 Human Hepatitis B Immunoglobulin (HBIG) Opportunities and Drivers
15.3 Human Hepatitis B Immunoglobulin (HBIG) Market Challenges
15.4 Human Hepatitis B Immunoglobulin (HBIG) Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Human Hepatitis B Immunoglobulin (HBIG) Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Region (2015-2020)
Table 5. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Region (2015-2020)
Table 6. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Region (2015-2020)
Table 8. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Forecast by Region (2021-2026)
Table 9. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share Forecast by Region (2021-2026)
Table 12. Global Human Hepatitis B Immunoglobulin (HBIG) (K Units) of Key Companies (2015-2020)
Table 13. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Company (2015-2020)
Table 14. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Company (2015-2020)
Table 16. Global Human Hepatitis B Immunoglobulin (HBIG) by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Human Hepatitis B Immunoglobulin (HBIG) as of 2019)
Table 17. Global Human Hepatitis B Immunoglobulin (HBIG) Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Human Hepatitis B Immunoglobulin (HBIG) Manufacturing Sites and Area Served
Table 19. Manufacturers Human Hepatitis B Immunoglobulin (HBIG) Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Human Hepatitis B Immunoglobulin (HBIG) Players
Table 22. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 23. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2015-2020)
Table 24. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Human Hepatitis B Immunoglobulin (HBIG) Price (K Units) by Type (2015-2020)
Table 26. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Type (2021-2026)
Table 27. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2021-2026)
Table 29. Global Human Hepatitis B Immunoglobulin (HBIG) Price (K Units) by Type (2021-2026)
Table 30. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020)
Table 31. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2015-2020)
Table 32. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Human Hepatitis B Immunoglobulin (HBIG) Price (K Units) by Application (2015-2020)
Table 34. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2021-2026)
Table 35. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Share by Application (2021-2026)
Table 36. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2021-2026)
Table 38. Global Human Hepatitis B Immunoglobulin (HBIG) Price (K Units) by Application (2021-2026)
Table 39. United States Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Company (2015-2020)
Table 40. United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
Table 41. United States Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 42. United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 43. United States Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020)
Table 44. United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
Table 45. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Company (2015-2020)
Table 46. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
Table 47. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 48. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 49. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020)
Table 50. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 51. China Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Company (2015-2020)
Table 52. China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
Table 53. China Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 54. China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 55. China Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020)
Table 56. China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
Table 57. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Company (2015-2020)
Table 58. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
Table 59. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 60. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 61. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020)
Table 62. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Company (2015-2020)
Table 64. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 66. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 68. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
Table 69. India Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Company (2015-2020)
Table 70. India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company (2015-2020)
Table 71. India Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Type (2015-2020)
Table 72. India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type (2015-2020)
Table 73. India Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) by Application (2015-2020)
Table 74. India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application (2015-2020)
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. Baxter Human Hepatitis B Immunoglobulin (HBIG) Product
Table 79. Baxter Recent Development
Table 80. CSL Corporation Information
Table 81. CSL Description and Business Overview
Table 82. CSL Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. CSL Human Hepatitis B Immunoglobulin (HBIG) Product
Table 84. CSL Recent Development
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Bayer Human Hepatitis B Immunoglobulin (HBIG) Product
Table 89. Bayer Recent Development
Table 90. Grifols Corporation Information
Table 91. Grifols Description and Business Overview
Table 92. Grifols Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Grifols Human Hepatitis B Immunoglobulin (HBIG) Product
Table 94. Grifols Recent Development
Table 95. Octapharma Corporation Information
Table 96. Octapharma Description and Business Overview
Table 97. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Octapharma Human Hepatitis B Immunoglobulin (HBIG) Product
Table 99. Octapharma Recent Development
Table 100. Shanghai RAAS Corporation Information
Table 101. Shanghai RAAS Description and Business Overview
Table 102. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Shanghai RAAS Human Hepatitis B Immunoglobulin (HBIG) Product
Table 104. Shanghai RAAS Recent Development
Table 105. Hualan Biological Corporation Information
Table 106. Hualan Biological Description and Business Overview
Table 107. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Hualan Biological Human Hepatitis B Immunoglobulin (HBIG) Product
Table 109. Hualan Biological Recent Development
Table 110. China Biologic Corporation Information
Table 111. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. China Biologic Description and Business Overview
Table 113. China Biologic Human Hepatitis B Immunoglobulin (HBIG) Product
Table 114. China Biologic Recent Development
Table 115. Tiantan Biologic Corporation Information
Table 116. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Tiantan Biologic Description and Business Overview
Table 118. Tiantan Biologic Human Hepatitis B Immunoglobulin (HBIG) Product
Table 119. Tiantan Biologic Recent Development
Table 120. Shuanglin Bio-pharmacy Corporation Information
Table 121. Shuanglin Bio-pharmacy Description and Business Overview
Table 122. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Shuanglin Bio-pharmacy Human Hepatitis B Immunoglobulin (HBIG) Product
Table 124. Shuanglin Bio-pharmacy Recent Development
Table 125. Sichuan Yuanda Shuyang Corporation Information
Table 126. Sichuan Yuanda Shuyang Description and Business Overview
Table 127. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Sichuan Yuanda Shuyang Human Hepatitis B Immunoglobulin (HBIG) Product
Table 129. Sichuan Yuanda Shuyang Recent Development
Table 130. Boya Bio-pharmaceutical Corporation Information
Table 131. Boya Bio-pharmaceutical Description and Business Overview
Table 132. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Boya Bio-pharmaceutical Human Hepatitis B Immunoglobulin (HBIG) Product
Table 134. Boya Bio-pharmaceutical Recent Development
Table 135. Shanghai Institute of Biological Corporation Information
Table 136. Shanghai Institute of Biological Description and Business Overview
Table 137. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Shanghai Institute of Biological Human Hepatitis B Immunoglobulin (HBIG) Product
Table 139. Shanghai Institute of Biological Recent Development
Table 140. Production Base and Market Concentration Rate of Raw Material
Table 141. Key Suppliers of Raw Materials
Table 142. Human Hepatitis B Immunoglobulin (HBIG) Distributors List
Table 143. Human Hepatitis B Immunoglobulin (HBIG) Customers List
Table 144. Human Hepatitis B Immunoglobulin (HBIG) Market Key Trends
Table 145. Human Hepatitis B Immunoglobulin (HBIG) Key Opportunities and Drivers
Table 146. Human Hepatitis B Immunoglobulin (HBIG) Market Challenges
Table 147. Research Programs/Design for This Report
Table 148. Key Data Information from Secondary Sources
Table 149. Key Data Information from Primary Sources
List of Figures
Figure 1. Human Hepatitis B Immunoglobulin (HBIG) Product Picture
Figure 2. Global Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Human Hepatitis B Immunoglobulin (HBIG) Market Share by Application in 2020 & 2026
Figure 6. Positive Infants Born to Mothers With Hepatitis B Surface Antigen (HBsAg) Examples
Figure 7. Unexpected Crowd of Hepatitis B Infection Examples
Figure 8. Close Contacts of Patients with Hepatitis B and Hepatitis B Virus Carriers Examples
Figure 9. Global Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Growth Rate (2015-2026)
Figure 10. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Human Hepatitis B Immunoglobulin (HBIG) Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 12. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Human Hepatitis B Immunoglobulin (HBIG) Sales (K Units) Growth Rate (2015-2026)
Figure 16. Europe Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Human Hepatitis B Immunoglobulin (HBIG) Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Human Hepatitis B Immunoglobulin (HBIG) Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Human Hepatitis B Immunoglobulin (HBIG) Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Human Hepatitis B Immunoglobulin (HBIG) Players Market Share by Revenue in Human Hepatitis B Immunoglobulin (HBIG) 2015 & 2019
Figure 27. Human Hepatitis B Immunoglobulin (HBIG) Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Type (2015-2020)
Figure 29. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Share by Application (2015-2020)
Figure 31. Global Human Hepatitis B Immunoglobulin (HBIG) Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 33. United States Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 34. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company in 2019
Figure 35. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 36. Europe Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application in 2019
Figure 37. China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company in 2019
Figure 38. China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 39. China Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application in 2019
Figure 40. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company in 2019
Figure 41. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 42. Japan Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application in 2019
Figure 43. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company in 2019
Figure 44. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 45. Southeast Asia Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application in 2019
Figure 46. India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Company in 2019
Figure 47. India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Type in 2019
Figure 48. India Human Hepatitis B Immunoglobulin (HBIG) Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Human Hepatitis B Immunoglobulin (HBIG)
Figure 51. Manufacturing Process Analysis of Human Hepatitis B Immunoglobulin (HBIG)
Figure 52. Human Hepatitis B Immunoglobulin (HBIG) Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
ヒトB型肝炎免疫グロブリン（IM）の世界市場レポート2020 Market Analysis and Insights: Global Human Hepatitis B Immunoglobulin (IM) Market The global Human Hepatitis B Immunoglobulin (IM) market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Human Hepatitis B Immunoglobulin (IM) Sc…- ヒト用ワクチンの世界市場レポート2020 A vaccine is a biological preparation that provides active acquired immunity to a particular disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins or one of its surface proteins. China …
- ヒト凝固因子VIIの世界市場レポート2020 Human Coagulation Factor VII is one of the proteins that cause blood to clot in the coagulation cascade. It is an enzyme of the serine protease class. It is sometimes used unlicensed in severe uncontrollable bleeding, although there have been safety concerns. A bio similar form of recombinant activa…
- ヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Human Endostatin Market The global Human Endostatin marke…
- 組換えヒトエンドスタチンの世界市場レポート2020 Endostatin is a naturally occurring, 20-kDa C-terminal fragment derived from type XVIII collagen. Human monomeric endostatin is a globular protein containing two disulfide bonds: Cys162−302 and Cys264−294. Market Analysis and Insights: Global Recombinant Human Endostatin Market The global Recombinan…